The association between cannabis use, mental illness and suicidal behaviour: what is the role of hopelessness
- Authors: Serafini, Gianluca , Pompili, Maurizio , Innamorati, Marco , Amore, Mario , Borgwardt, Stefan , Giradi, Paolo , Temple, Elizabeth
- Date: 2013
- Type: Text , Journal article
- Relation: Frontiers in Pyschiatry Vol. 4, no. (2013), p. 1-5
- Full Text: false
- Reviewed:
- Description: Cannabis is one of the most common illegal psychoactive substance used in European countries, in particular among adolescents and young adults (1). It has been estimated that almost 55% of adolescents aged 15–19 years have used cannabis at least once in their lifetime (2), while past year use is reported by approximately 30% of 15–17 year olds and over 47% of those aged 18–19 years (3). Cannabis use has been associated with several adverse life outcomes including unemployment, legal problems, dependence, early school leaving, increased risk of developing both psychotic and affective disorders (3, 4) together with brain structural and functional abnormalities (5, 6). An association between cannabis use, psychiatric disorders and suicidal behavior has also frequently been reported, although the exact nature of this link is still poorly understood (4).
Cannabis use and anxiety : Is stress the missing piece of the puzzle?
- Authors: Temple, Elizabeth , Driver, Matthew , Brown, Rhonda
- Date: 2014
- Type: Text , Journal article
- Relation: Frontiers in Psychiatry Vol. 5, no. (2014), p. 1-13
- Full Text:
- Reviewed:
- Description: Objective: Comorbidity between anxiety and cannabis use is common yet the nature of the association between these conditions is not clear. Four theories were assessed, and a fifth hypothesis tested to determine if the misattribution of stress symptomology plays a role in the association between state-anxiety and cannabis. Methods: Three-hundred-sixteen participants ranging in age from 18 to 71 years completed a short online questionnaire asking about their history of cannabis use and symptoms of stress and anxiety. Results: Past and current cannabis users reported higher incidence of lifetime anxiety than participants who had never used cannabis; however, these groups did not differ in state-anxiety, stress, or age of onset of anxiety. State-anxiety and stress were not associated with frequency of cannabis use, but reported use to self-medicate for anxiety was positively associated with all three. Path analyses indicated two different associations between anxiety and cannabis use, pre-existing and high state-anxiety was associated with (i) higher average levels of intoxication and, in turn, acute anxiety responses to cannabis use; (ii) frequency of cannabis use via the mediating effects of stress and self-medication. Conclusion: None of the theories was fully supported by the findings. However, as cannabis users reporting self-medication for anxiety were found to be self-medicating stress symptomology, there was some support for the stress-misattribution hypothesis. With reported self-medication for anxiety being the strongest predictor of frequency of use, it is suggested that researchers, clinicians, and cannabis users pay greater attention to the overlap between stress and anxiety symptomology and the possible misinterpretation of these related but distinct conditions. © 2014 Temple, Driver and Brown.